|
|
The present invention relates to powdered, crosslinked polymer compositions, containing
a) 55-99.9 wt.-% of at least one polymerized, ethylenically unsaturated,
polymerizable monomer which contains acid groups neutralized to at least 25 mole-%,
b) 0-40 wt.-% of polymerized, unsaturated monomers copolymerizable with a),
c) 0.01-5.0 wt.-%, preferably 0.1-2.0 wt.-% of one or more crosslinking agents,
d) 0-30 wt.-% of a water-soluble polymer,
the weight amounts a) through d) being based on anhydrous polymer composition,
and the sum of these components always being 100 wt.-%, which compositions can
be obtained by continuous polymerization wherein at least one parameter biasing
the polymerization is varied according to a recurring pattern. The present invention
also relates to a process for their production and to their use.
|
|
|
< Muscarinic receptor agonists
< .beta.3 adrenergic receptor agonists
> 1,3-dihydro-2H-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
> Pyrazino[1,2:1,6]pyrido[3,4b]indole derivatives
|
~ 00191
|